Asceneuron

0 followers


Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.

Industries

+1

Headquarters

Stage

Employees

Links

Org chart

Ryan Schubert
SVP, Translational Medicine & Clinical Strategy
Ruhi Ahmed
SVP & Head of Regulatory Affairs
Pearl Fang
VP & Head of Clinical Development
Anna Quattropani
Head of Non-Clinical Development & Medicinal Chemistry
Rolf Pokorny
Head of Early Clinical Development
Colin Kahrs
Head of Intellectual Property
Manfred Schneider
Head of ADME & Toxicology
Bruno Permanne
Senior Director & Head of Preclinical Development